v3 Template
H

Hemanext Inc.

Biomedical Technology / Transfusion Medicine ~500 employees
Founded
--
Employees (Est.)
~500
25 leaders known
Total Funding
$41.8M
Funding Rounds
3
Last Funding
2025-10-14

About Hemanext Inc.

Hemanext is a global biomedical technology pioneer in transfusion medicine, committed to optimizing the therapeutic impact and value of blood for patients and healthcare systems. Their mission is to improve the standard of care for patients relying on transfusions by enhancing the quality, functionality, and viability of stored red blood cells (RBCs) through innovative technologies and research on hypoxic storage.

Products & Services

Hemanext ONE:The first FDA-authorized processing and storage technology proven to mitigate the red blood cell (RBC) storage lesion.
Hemanext ONE

Specialties

Blood Processing Blood Storage Transfusion Technology Hypoxic Storage of Red Blood Cells Red Blood Cell Quality and Characterization Oxygen-controlled RBC storage Transfusion medicine Blood preservation technology

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: SBIR Phase II Grant
T: -
FT: SBIR Phase II Grant
A: 2900000
MR: -
FA: $2.9M
FAN: 2900000
D: 2025-10-14
FD: 2025-10-14
1 investors
2 RT: Series B-3
T: -
FT: Series B-3
A: 18900000
MR: -
FA: $18.9 million
FAN: 18900000
D: 2025-07-22
FD: 2025-07-22
-
3 RT: Series B-2 Equity
T: -
FT: Series B-2 Equity
A: 20000000
MR: -
FA: just over $20 million
FAN: 20000000
D: 2025-01-27
FD: 2025-01-27
-
SBIR Phase II Grant Latest
2025-10-14
$2.9M
1 investor (Pro only)
Series B-3 2025-07-22
$18.9M
Series B-2 Equity 2025-01-27
$20.0M

View 2 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

M

M. Shane Ray

CEO & Chief Commercial Officer

A

Andrew Dunham

Chief Scientific Officer

E

Eric Newman

Chief Financial Officer

L

Laurel Omert

Chief Medical Officer

D

Daan Kok

Head of BD & Strategy

L

Laura Daniels

VP Product Development

View 22 more team members with Pro

Unlock Full Team Directory

Recent News

Hemanext Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biomedical Technology / Transfusion Medicine
Company Size
~500 employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro